Stop Decolsin (Dextromethorphan) Immediately
Dextromethorphan should not be used in children for cough, as multiple high-quality guidelines from the American Academy of Pediatrics and American College of Chest Physicians demonstrate it has no efficacy beyond placebo and is associated with significant adverse events including potential mortality. 1, 2
Why Dextromethorphan Must Be Discontinued
- No proven benefit: Systematic reviews conclusively show that dextromethorphan is no different than placebo in reducing nocturnal cough or sleep disturbance in children 1, 2
- Safety concerns: Over-the-counter cough medications containing dextromethorphan have been associated with significant morbidity and even mortality in children, particularly those under 5 years of age 1
- Official warnings: The FDA has issued warnings against using these OTC medications in young children, and manufacturers have voluntarily relabeled products as "do not use in children under 4 years of age" 1
What to Give Instead: Evidence-Based Alternatives
For Children Over 1 Year Old
Give honey as first-line treatment - it provides more relief for cough symptoms than no treatment, diphenhydramine, or placebo (though not superior to dextromethorphan, which itself is ineffective) 1, 2
Critical Safety Warning
- Never give honey to infants under 12 months due to risk of infant botulism 2
Next Steps: Determine the Underlying Cause
Immediate Assessment Required
Evaluate for specific cough characteristics that guide treatment 1, 2:
Red flags requiring immediate further investigation 3:
- Coughing with feeding
- Digital clubbing
- Failure to thrive or poor growth
- Dysphagia
- Hemoptysis
If Wet/Productive Cough Present
Start antibiotics targeting common respiratory bacteria for 2 weeks - this represents protracted bacterial bronchitis until proven otherwise 3
- Reassess at 2 weeks; if resolved, diagnosis confirmed 3
- If persists, continue antibiotics for additional 2 weeks 3
- If still present after 4 weeks total, refer for bronchoscopy and further investigation 3
If Dry Cough with Asthma Risk Factors
Consider a trial of low-dose inhaled corticosteroids (400 μg/day budesonide or beclomethasone equivalent) for 2-4 weeks 1, 2
- Reassess in 2-4 weeks 1
- If no response, do not increase the dose - withdraw medication and consider other diagnoses 1
- If cough resolves, re-evaluate after stopping treatment as resolution may be spontaneous 1
If High Fever Present
Consider beta-lactam antibiotics if fever ≥38.5°C persists for more than 3 days, particularly if pneumonia is suspected 2
Environmental Modifications Essential
- Evaluate and eliminate tobacco smoke exposure in all children with cough 1, 2
- Address other environmental pollutants 1, 2
Common Pitfalls to Avoid
- Do not prescribe OTC medications due to parental pressure despite lack of efficacy 2
- Do not empirically treat for asthma, GERD, or upper airway cough syndrome without clinical features consistent with these conditions 2, 3
- Do not use antihistamines - they have minimal to no efficacy for cough relief in children and are associated with adverse events 1, 2
- Avoid codeine-containing medications due to potential for serious side effects including respiratory distress 1, 2